AARD — AARDVARK THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.76 | — | -0.42 | -1.11 | 8 | +2−4 |
| Mar 2027 | -0.62 | — | -0.44 | -0.87 | 3 | +2−1 |
| Jun 2027 | -0.61 | — | -0.43 | -0.88 | 3 | +2−1 |
| Sep 2027 | -0.52 | — | -0.40 | -0.62 | 3 | +2−1 |
| Dec 2027 | -0.56 | — | -0.43 | -0.63 | 3 | −2 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -3.17 | — | -2.58 | -3.63 | 9 | +3−4 |
| Dec 2027 | -2.49 | — | -1.42 | -3.56 | 9 | +3−3 |
| Dec 2028 | -2.31 | — | -0.94 | -3.53 | 5 | +2−2 |
| Dec 2029 | -1.44 | — | -0.75 | -2.13 | 2 | −1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 79 SEC-registered investment managers reported holding AARD (AARDVARK THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $45.88M across 8.71M shares. That is -2.9% by share count (-233.96K shares) versus the previous quarter, while reported value moved -11.1%. Ownership is concentrated: the five largest holders account for 75.2% of reported value and the top ten for 83.5%.
Compared with the prior quarter, 15 opened new positions, 19 added to existing stakes, 29 trimmed, 11 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of AARDVARK THERAPEUTICS INC (AARD) include Decheng Capital LLC, Cormorant Asset Management, LP, Vanguard Group, ranked by reported 13F value among the 136 institutional holders on this page.
AARD is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 79 | 8.71M | $45.88M | -4.5% |
| Q2 2026 | 74 | 8.45M | $48.70M | -3.2% |
| Q1 2026 | 83 | 9.29M | $35.02M | -23.3% |
| Q4 2025 | 67 | 11.26M | $147.76M | +10.2% |
| Q3 2025 | 50 | 9.79M | $130.17M | +9.0% |
| Q2 2025 | 36 | 8.93M | $120.73M | +13.8% |
| Q1 2025 | 26 | 8.74M | $65.50M | — |
Over the 7 quarters shown, institutional share counts decreased 0% in aggregate (Q1 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (-23.3%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $20.64M | 3.01% | Hold | |
| 1.03M | $5.45M | 0.30% | Hold | |
| 720.03K | $3.79M | 0.18% | Add | |
| 557.93K | $2.94M | 0.00% | Reduce | |
| 316.43K | $1.67M | 0.01% | New | |
| 194.62K | $1.03M | 0.00% | Add | |
| 139.01K | $732.96K | 0.00% | Reduce | |
| 132.20K | $696.72K | 0.00% | Add | |
| 130.16K | $685.97K | 0.00% | New | |
| 129.58K | $682.87K | 0.00% | Add | |
| 114.05K | $601.06K | 0.00% | Reduce | |
| 114.05K | $601.06K | 0.00% | Reduce | |
| 92.89K | $489.54K | 0.00% | Add | |
| 91.68K | $483.16K | 0.02% | Reduce | |
| 85.87K | $452.52K | 0.43% | New | |
| 75.17K | $396.16K | 0.00% | Hold | |
| 62.45K | $329.13K | 0.00% | Reduce | |
| 62.45K | $329.13K | 0.00% | Reduce | |
| 60.98K | $321.34K | 0.00% | Add | |
| 57.57K | $303.41K | 0.00% | Reduce | |
| 54.13K | $285.25K | 0.01% | Add | |
| 50.00K | $263.50K | 0.00% | Reduce | |
| 40.56K | $213.74K | 0.00% | New | |
| 40.56K | $213.74K | 0.00% | New | |
| 35.46K | $186.85K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $22.56M | 3.08% | Hold | |
| 1.03M | $5.96M | 0.33% | Hold | |
| 562.88K | $3.24M | 0.00% | Add | |
| 480.25K | $2.77M | 0.00% | Add | |
| 480.25K | $2.77M | 0.00% | Add | |
| 300.00K | $1.73M | 0.00% | Hold | |
| 187.04K | $1.08M | 0.00% | Reduce | |
| 149.84K | $863.53K | 0.00% | New | |
| 149.84K | $863.53K | 0.00% | Reduce | |
| 116.58K | $671.51K | 0.02% | Add | |
| 108.38K | $624.25K | 0.00% | Reduce | |
| 79.28K | $456.68K | 0.00% | Add | |
| 75.17K | $432.99K | 0.00% | Reduce | |
| 72.43K | $417.19K | 0.00% | Hold | |
| 69.95K | $402.90K | 0.00% | Reduce | |
| 69.95K | $402.90K | 0.00% | Reduce | |
| 59.10K | $340.42K | 0.00% | Add | |
| 40.50K | $233.28K | 0.01% | New | |
| 38.38K | $221.08K | 0.00% | Add | |
| 35.64K | $205.28K | 0.00% | Reduce | |
| 30.18K | $173.82K | 0.00% | Add | |
| 28.08K | $161.74K | 0.00% | Reduce | |
| 26.30K | $151.48K | 0.00% | Reduce | |
| 24.03K | $138.43K | 0.00% | Reduce | |
| 24.02K | $138.38K | 0.00% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $14.77M | 2.23% | Hold | |
| 1.03M | $3.90M | 0.43% | Add | |
| 792.57K | $2.99M | 0.00% | Add | |
| 554.10K | $2.09M | 0.00% | New | |
| 316.62K | $1.19M | 0.23% | New | |
| 309.45K | $1.17M | 0.00% | Add | |
| 300.00K | $1.13M | 0.00% | New | |
| 199.32K | $751.44K | 0.00% | Add | |
| 163.35K | $615.85K | 0.00% | Add | |
| 157.89K | $595.24K | 0.00% | Add | |
| 134.50K | $507.05K | 0.00% | New | |
| 134.50K | $507.05K | 0.00% | New | |
| 98.33K | $370.72K | 0.00% | Reduce | |
| 98.33K | $370.72K | 0.00% | Reduce | |
| 88.60K | $334.02K | 0.00% | Reduce | |
| 83.21K | $313.70K | 0.00% | New | |
| 75.15K | $283.31K | 0.00% | New | |
| 72.43K | $273.06K | 0.00% | New | |
| 70.79K | $266.89K | 0.00% | New | |
| 66.68K | $251.39K | 0.01% | Reduce | |
| 52.90K | $199.43K | 0.00% | Reduce | |
| 46.27K | $174.42K | 0.00% | Add | |
| 43.26K | $163.09K | 0.00% | New | |
| 33.68K | $126.99K | 0.02% | Reduce | |
| 30.64K | $115.50K | 0.01% | New |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $51.41M | 6.92% | Hold | |
| 1.29M | $16.92M | 0.02% | Reduce | |
| 1.01M | $13.32M | 0.93% | Reduce | |
| 784.43K | $10.30M | 0.00% | Add | |
| 717.43K | $9.42M | 0.00% | Add | |
| 483.34K | $6.34M | 0.00% | Add | |
| 483.34K | $6.34M | 0.01% | Add | |
| 476.60K | $6.26M | 5.71% | New | |
| 303.94K | $3.99M | 0.60% | Reduce | |
| 297.87K | $3.91M | 0.00% | Add | |
| 158.24K | $2.08M | 0.00% | Add | |
| 128.79K | $1.69M | 0.00% | Add | |
| 97.52K | $1.28M | 0.06% | New | |
| 91.68K | $1.20M | 0.04% | Reduce | |
| 89.30K | $1.17M | 0.00% | Add | |
| 77.95K | $1.02M | 0.00% | Add | |
| 69.50K | $912.13K | 0.49% | New | |
| 53.35K | $700.21K | 0.00% | Add | |
| 50.13K | $657.97K | 0.00% | Reduce | |
| 46.41K | $609.11K | 0.52% | New | |
| 41.02K | $538.41K | 0.00% | New | |
| 36.92K | $484.60K | 0.00% | New | |
| 35.92K | $472.00K | 0.04% | New | |
| 34.58K | $453.80K | 0.01% | New | |
| 31.53K | $413.87K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $52.06M | 9.08% | Hold | |
| 1.36M | $18.07M | 0.03% | Add | |
| 1.05M | $13.95M | 0.58% | Add | |
| 555.72K | $7.39M | 0.00% | Add | |
| 350.00K | $4.65M | 0.01% | Add | |
| 319.62K | $4.25M | 0.01% | New | |
| 319.62K | $4.25M | 0.00% | New | |
| 309.46K | $4.11M | 0.00% | Add | |
| 306.91K | $4.08M | 0.58% | Add | |
| 253.75K | $3.37M | 0.03% | Reduce | |
| 194.03K | $2.58M | 0.00% | Add | |
| 141.78K | $1.88M | 0.02% | New | |
| 96.68K | $1.28M | 0.04% | Add | |
| 93.00K | $1.24M | 0.00% | Add | |
| 68.46K | $909.86K | 0.00% | Add | |
| 63.57K | $844.83K | 0.00% | New | |
| 57.20K | $760.15K | 0.00% | Add | |
| 56.55K | $751.50K | 0.00% | Add | |
| 54.73K | $727.34K | 0.00% | Add | |
| 39.93K | $530.62K | 0.00% | Reduce | |
| 25.70K | $341.55K | 0.00% | New | |
| 23.93K | $318.03K | 0.00% | Add | |
| 22.00K | $292.38K | 0.01% | New | |
| 19.45K | $258.45K | 0.00% | New | |
| 18.93K | $251.54K | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.92M | $52.96M | 13.38% | Hold | |
| 1.28M | $17.36M | 0.03% | Add | |
| 989.07K | $13.37M | 0.48% | Add | |
| 800.19K | $10.82M | 0.81% | Hold | |
| 460.98K | $6.23M | 0.00% | Add | |
| 286.81K | $3.88M | 0.80% | Add | |
| 279.26K | $3.78M | 0.03% | Add | |
| 205.79K | $2.78M | 0.00% | Add | |
| 175.00K | $2.37M | 0.00% | Reduce | |
| 136.93K | $1.85M | 0.00% | Add | |
| 76.68K | $1.04M | 0.07% | Add | |
| 51.92K | $702.01K | 0.00% | Add | |
| 50.56K | $683.54K | 0.00% | New | |
| 45.09K | $609.55K | 0.00% | Add | |
| 37.31K | $504.46K | 0.00% | New | |
| 35.49K | $479.88K | 0.00% | Add | |
| 18.59K | $251.40K | 0.00% | Reduce | |
| 14.24K | $192.53K | 0.00% | New | |
| 14.24K | $192.53K | 0.00% | New | |
| 8.96K | $121.14K | 0.00% | Add | |
| 7.99K | $108.01K | 0.00% | Add | |
| 7.30K | $98.70K | 0.00% | New | |
| 5.72K | $77.40K | 0.00% | New | |
| 5.49K | $74.20K | 0.00% | New | |
| 3.24K | $43.79K | 0.00% | New |
New Positions (Q3 2026)
- ExodusPoint Capital Management, LP 316.43K sh · $1.67M
- JACOBS LEVY EQUITY MANAGEMENT, INC 130.16K sh · $685.97K
- Velan Capital Investment Management LP 85.87K sh · $452.52K
- D. E. Shaw & Co., Inc. 40.56K sh · $213.74K
- D. E. Shaw & Co 40.56K sh · $213.74K
- Empowered Funds, LLC 23.60K sh · $124.38K
- DIMENSIONAL FUND ADVISORS LP 17.71K sh · $93.33K
- Schonfeld Strategic Advisors LLC 15.94K sh · $84.01K
- Verdad Advisers, LP 14.95K sh · $78.80K
- Quadrature Capital Ltd 12.27K sh · $64.67K
- GSA CAPITAL PARTNERS LLP 11.81K sh · $62.00K
- Trexquant Investment LP 10.33K sh · $54.43K
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 149.84K sh · $863.53K
- Woodline Partners LP sold 72.43K sh · $417.19K
- Mariner, LLC sold 21.78K sh · $125.41K
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC sold 10.43K sh · $79.30K
- PRELUDE CAPITAL MANAGEMENT, LLC sold 12.43K sh · $71.57K
- MERCER GLOBAL ADVISORS INC /ADV sold 11.46K sh · $66.03K
- Cerity Partners LLC sold 10.77K sh · $62.04K
- Integrated Wealth Concepts LLC sold 1.94K sh · $11.19K
- Wealth Enhancement Trust Services, Inc. sold 48 sh · $276
- Clearstead Advisors, LLC sold 39 sh · $226
- SJS Investment Consulting Inc. sold 16 sh · $93
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | 3.92M | 3.92M | 3.92M | 3.92M | 3.92M | 3.92M |
| Laurion Capital Management LP | 1.03M | 1.03M | 1.03M | 1.01M | 1.05M | 989.07K | 808.24K |
| EcoR1 Capital, LLC | 720.03K | 14.70K | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 557.93K | 562.88K | 554.10K | — | — | — | — |
| ExodusPoint Capital Management, LP | 316.43K | — | — | — | — | — | — |
| BlackRock Inc | 194.62K | 187.04K | 792.57K | 784.43K | 309.46K | 205.79K | 18.78K |
| Geode Capital Management | 139.01K | 149.84K | 309.45K | 297.87K | 194.03K | 136.93K | 59.60K |
| Marshall Wace | 132.20K | 19.08K | — | — | — | — | — |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 130.16K | — | — | — | — | — | — |
| Two Sigma Investments | 129.58K | 108.38K | 163.35K | 128.79K | 63.57K | — | 15.42K |
| AQR Capital Management | 114.05K | 480.25K | 134.50K | — | — | — | — |
| AQR CAPITAL MANAGEMENT LLC | 114.05K | 480.25K | 134.50K | — | — | — | — |
| RAYMOND JAMES FINANCIAL INC | 92.89K | 79.28K | 10.89K | — | — | — | — |
| CANTOR FITZGERALD, L. P. | 91.68K | 116.58K | 66.68K | 91.68K | 96.68K | 76.68K | 66.68K |
| Velan Capital Investment Management LP | 85.87K | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 75.17K | 75.17K | 83.21K | — | — | — | — |
| Millennium Management | 62.45K | 69.95K | 98.33K | 483.34K | 319.62K | — | 65.64K |
| MILLENNIUM MANAGEMENT LLC | 62.45K | 69.95K | 98.33K | 483.34K | 319.62K | — | 65.64K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 60.98K | 24.02K | — | — | — | — | — |
| STATE STREET CORP | 57.57K | — | 199.32K | 158.24K | 93.00K | 37.31K | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold AARD?
As of 2026-Q3, 79 institutional funds reported holding AARD (AARDVARK THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $45.88M.
How many shares of AARD do institutions own?
13F filers reported 8.71M shares of AARD, worth $45.88M in aggregate at the end of 2026-Q3.
Is institutional ownership of AARD rising or falling?
Share counts moved -2.9% versus the prior quarter — distribution.
Who are the top institutional holders of AARD?
The largest 13F holders are Decheng Capital LLC, Cormorant Asset Management, LP, Vanguard Group, SymBiosis Capital Partners, LLC, Laurion Capital Management LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of AARDVARK THERAPEUTICS INC?
The major shareholders of AARDVARK THERAPEUTICS INC (AARD) by reported 13F value are Decheng Capital LLC, Cormorant Asset Management, LP, Vanguard Group, SymBiosis Capital Partners, LLC, Laurion Capital Management LP, among 136 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.